You just read:

Actinium to Highlight Targeted Conditioning Portfolio at 2020 Transplantation & Cellular Therapy Annual Meeting; Phase 3 SIERRA Trial Preliminary Results Selected for Oral Presentation

News provided by

Actinium Pharmaceuticals, Inc.

Feb 13, 2020, 08:03 ET